517
Views
15
CrossRef citations to date
0
Altmetric
Research report

The effective use of fear appeals in persuasive immunization: An analysis of national immunization intervention messages

Pages 264-292 | Published online: 21 May 2009
 

Abstract

This paper reports application of a theoretical persuasive health message framework grounded in literature on fear appeals, message design logic, and health persuasion theory to assess the effectiveness of the materials used most frequently by national immunization organizations in the United States. The severity of the problem of inadequate preschool immunization with its associated target audience and barriers is identified. Analysis revealed that national immunization message designers are creating materials most likely to match what health communication research would recommend along the dimension of response efficacy (i.e., showing parents that attaining immunizations is realistic, available, affordable, safe, and effectively prevents specific diseases). However the materials were least likely to match along the dimension of self‐efficacy (i.e., building parents’ beliefs that they have the ability and motivation to perform preventive immunization behavior for their children). Implications for practitioners in developing more effective immunization fear appeals, and suggestions for future research in the area, are addressed in the Conclusion.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.